Moderna Begins Injecting 4,000 Adults With modRNA Bird Flu Pandemic Vaccine

Moderna Begins Injecting 4,000 Adults With modRNA Bird Flu Pandemic Vaccine

This post was published by Jon Fleetwood. Support him by subscribing at Substack and following at Instagram / X / Facebook. In a major acceleration of bird flu pandemic orchestration and mass vaccination infrastructure, Moderna, Inc. yesterday announced that “the first participants in the U.S. and UK have been dosed in a Phase 3 study of the Company’s investigational mRNA-based H5 pandemic influenza vaccine candidate, mRNA-1018.” This is the fi…

Bird Flu Vaccine Trial Launches To Prepare For Potential Pandemic

Researchers have delivered the UK’s first dose in a new trial using an investigational mRNA vaccine to protect people against potential influenza pandemics such as avian flu (also known as ‘bird flu’). The research will assess the safety and immune response of an investigational mRNA-based A(H5) pandemic influenza vaccine candidate, mRNA-1018, commonly circulating in birds, with pandemic potential. The study is supported by NIHR and sponsored by…